found that combination therapy with aliskiren and ARBs decreased proteinuria in non-DM CKD patients more effectively than monotherapy alone, however their findings did not reach statistical significance due to the limited number of patients (n = 12 in each group) [ 32 ].
← all excerpts
Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease.
1
—
—